nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Ethynodiol—ESR1—liver cancer	0.0086	0.701	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—liver cancer	0.00366	0.299	CrCbGaD
Cyproterone acetate—Hepatomegaly—Epirubicin—liver cancer	0.003	0.00447	CcSEcCtD
Cyproterone acetate—Thrombosis—Epirubicin—liver cancer	0.003	0.00447	CcSEcCtD
Cyproterone acetate—Cyst—Doxorubicin—liver cancer	0.00294	0.00438	CcSEcCtD
Cyproterone acetate—Haemoglobin—Sorafenib—liver cancer	0.0029	0.00433	CcSEcCtD
Cyproterone acetate—Haemorrhage—Sorafenib—liver cancer	0.00288	0.0043	CcSEcCtD
Cyproterone acetate—Hyperventilation—Doxorubicin—liver cancer	0.00285	0.00426	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Sorafenib—liver cancer	0.00283	0.00423	CcSEcCtD
Cyproterone acetate—Hypercalcaemia—Doxorubicin—liver cancer	0.00283	0.00422	CcSEcCtD
Cyproterone acetate—Hepatomegaly—Doxorubicin—liver cancer	0.00277	0.00414	CcSEcCtD
Cyproterone acetate—Thrombosis—Doxorubicin—liver cancer	0.00277	0.00414	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Sorafenib—liver cancer	0.00273	0.00407	CcSEcCtD
Cyproterone acetate—Angiopathy—Sorafenib—liver cancer	0.00262	0.0039	CcSEcCtD
Cyproterone acetate—Immune system disorder—Sorafenib—liver cancer	0.00261	0.00389	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Sorafenib—liver cancer	0.0026	0.00388	CcSEcCtD
Cyproterone acetate—Alopecia—Sorafenib—liver cancer	0.00255	0.0038	CcSEcCtD
Cyproterone acetate—Mental disorder—Sorafenib—liver cancer	0.00253	0.00377	CcSEcCtD
Cyproterone acetate—Malnutrition—Sorafenib—liver cancer	0.00251	0.00375	CcSEcCtD
Cyproterone acetate—Breast pain—Epirubicin—liver cancer	0.00243	0.00363	CcSEcCtD
Cyproterone acetate—Jaundice cholestatic—Epirubicin—liver cancer	0.00242	0.0036	CcSEcCtD
Cyproterone acetate—Cardiovascular disorder—Epirubicin—liver cancer	0.00242	0.0036	CcSEcCtD
Cyproterone acetate—Skin discolouration—Epirubicin—liver cancer	0.00235	0.00351	CcSEcCtD
Cyproterone acetate—Anaemia—Sorafenib—liver cancer	0.00232	0.00346	CcSEcCtD
Cyproterone acetate—Cough increased—Epirubicin—liver cancer	0.00232	0.00346	CcSEcCtD
Cyproterone acetate—Glossitis—Epirubicin—liver cancer	0.0023	0.00344	CcSEcCtD
Cyproterone acetate—Syncope—Sorafenib—liver cancer	0.00225	0.00336	CcSEcCtD
Cyproterone acetate—Breast pain—Doxorubicin—liver cancer	0.00225	0.00336	CcSEcCtD
Cyproterone acetate—Leukopenia—Sorafenib—liver cancer	0.00225	0.00335	CcSEcCtD
Cyproterone acetate—Jaundice cholestatic—Doxorubicin—liver cancer	0.00224	0.00334	CcSEcCtD
Cyproterone acetate—Cardiovascular disorder—Doxorubicin—liver cancer	0.00224	0.00334	CcSEcCtD
Cyproterone acetate—Creatinine increased—Epirubicin—liver cancer	0.00223	0.00333	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Sorafenib—liver cancer	0.00221	0.00329	CcSEcCtD
Cyproterone acetate—Cough—Sorafenib—liver cancer	0.00219	0.00327	CcSEcCtD
Cyproterone acetate—Gait disturbance—Epirubicin—liver cancer	0.00217	0.00324	CcSEcCtD
Cyproterone acetate—Skin discolouration—Doxorubicin—liver cancer	0.00217	0.00324	CcSEcCtD
Cyproterone acetate—Cough increased—Doxorubicin—liver cancer	0.00215	0.0032	CcSEcCtD
Cyproterone acetate—Glossitis—Doxorubicin—liver cancer	0.00213	0.00318	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00212	0.00317	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Epirubicin—liver cancer	0.00212	0.00317	CcSEcCtD
Cyproterone acetate—Injection site reaction—Epirubicin—liver cancer	0.00211	0.00315	CcSEcCtD
Cyproterone acetate—Creatinine increased—Doxorubicin—liver cancer	0.00206	0.00308	CcSEcCtD
Cyproterone acetate—Shock—Sorafenib—liver cancer	0.00202	0.00301	CcSEcCtD
Cyproterone acetate—Fluid retention—Epirubicin—liver cancer	0.00202	0.00301	CcSEcCtD
Cyproterone acetate—Gait disturbance—Doxorubicin—liver cancer	0.00201	0.003	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Sorafenib—liver cancer	0.00201	0.003	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Sorafenib—liver cancer	0.00201	0.00299	CcSEcCtD
Cyproterone acetate—Skin disorder—Sorafenib—liver cancer	0.00199	0.00297	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Doxorubicin—liver cancer	0.00196	0.00293	CcSEcCtD
Cyproterone acetate—Anorexia—Sorafenib—liver cancer	0.00195	0.00291	CcSEcCtD
Cyproterone acetate—Injection site reaction—Doxorubicin—liver cancer	0.00195	0.00291	CcSEcCtD
Cyproterone acetate—Coma—Epirubicin—liver cancer	0.00194	0.00289	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Epirubicin—liver cancer	0.00193	0.00288	CcSEcCtD
Cyproterone acetate—Neoplasm—Epirubicin—liver cancer	0.00192	0.00286	CcSEcCtD
Cyproterone acetate—Fluid retention—Doxorubicin—liver cancer	0.00186	0.00278	CcSEcCtD
Cyproterone acetate—Abnormal vision—Epirubicin—liver cancer	0.00185	0.00276	CcSEcCtD
Cyproterone acetate—Dyspnoea—Sorafenib—liver cancer	0.00183	0.00273	CcSEcCtD
Cyproterone acetate—Dyspepsia—Sorafenib—liver cancer	0.0018	0.00269	CcSEcCtD
Cyproterone acetate—Coma—Doxorubicin—liver cancer	0.00179	0.00268	CcSEcCtD
Cyproterone acetate—Phlebitis—Epirubicin—liver cancer	0.00179	0.00267	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Doxorubicin—liver cancer	0.00179	0.00266	CcSEcCtD
Cyproterone acetate—Decreased appetite—Sorafenib—liver cancer	0.00178	0.00266	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Epirubicin—liver cancer	0.00178	0.00266	CcSEcCtD
Cyproterone acetate—Neoplasm—Doxorubicin—liver cancer	0.00178	0.00265	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Epirubicin—liver cancer	0.00177	0.00264	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Sorafenib—liver cancer	0.00177	0.00264	CcSEcCtD
Cyproterone acetate—Fatigue—Sorafenib—liver cancer	0.00177	0.00264	CcSEcCtD
Cyproterone acetate—Constipation—Sorafenib—liver cancer	0.00175	0.00261	CcSEcCtD
Cyproterone acetate—Eczema—Epirubicin—liver cancer	0.00171	0.00256	CcSEcCtD
Cyproterone acetate—Hepatic failure—Epirubicin—liver cancer	0.00171	0.00256	CcSEcCtD
Cyproterone acetate—Abnormal vision—Doxorubicin—liver cancer	0.00171	0.00256	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Sorafenib—liver cancer	0.00168	0.0025	CcSEcCtD
Cyproterone acetate—Phlebitis—Doxorubicin—liver cancer	0.00165	0.00247	CcSEcCtD
Cyproterone acetate—Hot flush—Epirubicin—liver cancer	0.00165	0.00246	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Doxorubicin—liver cancer	0.00165	0.00246	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Doxorubicin—liver cancer	0.00164	0.00245	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Epirubicin—liver cancer	0.00163	0.00244	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Epirubicin—liver cancer	0.00163	0.00244	CcSEcCtD
Cyproterone acetate—Urticaria—Sorafenib—liver cancer	0.00163	0.00243	CcSEcCtD
Cyproterone acetate—Abdominal pain—Sorafenib—liver cancer	0.00162	0.00242	CcSEcCtD
Cyproterone acetate—Body temperature increased—Sorafenib—liver cancer	0.00162	0.00242	CcSEcCtD
Cyproterone acetate—Hepatic failure—Doxorubicin—liver cancer	0.00159	0.00237	CcSEcCtD
Cyproterone acetate—Eczema—Doxorubicin—liver cancer	0.00159	0.00237	CcSEcCtD
Cyproterone acetate—Cardiac failure—Epirubicin—liver cancer	0.00158	0.00236	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Epirubicin—liver cancer	0.00157	0.00235	CcSEcCtD
Cyproterone acetate—Hot flush—Doxorubicin—liver cancer	0.00152	0.00227	CcSEcCtD
Cyproterone acetate—Migraine—Epirubicin—liver cancer	0.00152	0.00226	CcSEcCtD
Cyproterone acetate—Affect lability—Epirubicin—liver cancer	0.00152	0.00226	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Doxorubicin—liver cancer	0.00151	0.00225	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00151	0.00225	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Sorafenib—liver cancer	0.00151	0.00225	CcSEcCtD
Cyproterone acetate—Asthenia—Sorafenib—liver cancer	0.00147	0.00219	CcSEcCtD
Cyproterone acetate—Cardiac failure—Doxorubicin—liver cancer	0.00146	0.00218	CcSEcCtD
Cyproterone acetate—Mood swings—Epirubicin—liver cancer	0.00146	0.00218	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Doxorubicin—liver cancer	0.00145	0.00217	CcSEcCtD
Cyproterone acetate—Pruritus—Sorafenib—liver cancer	0.00145	0.00216	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Epirubicin—liver cancer	0.00144	0.00215	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Epirubicin—liver cancer	0.00142	0.00212	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—liver cancer	0.0014	0.00209	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—liver cancer	0.0014	0.00209	CcSEcCtD
Cyproterone acetate—Diarrhoea—Sorafenib—liver cancer	0.0014	0.00209	CcSEcCtD
Cyproterone acetate—Breast disorder—Epirubicin—liver cancer	0.00139	0.00208	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00139	0.00207	CcSEcCtD
Cyproterone acetate—Muscular weakness—Epirubicin—liver cancer	0.00136	0.00203	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00136	0.00203	CcSEcCtD
Cyproterone acetate—Dizziness—Sorafenib—liver cancer	0.00136	0.00202	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—liver cancer	0.00135	0.00202	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—liver cancer	0.00134	0.00199	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—liver cancer	0.00133	0.00199	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—liver cancer	0.00132	0.00196	CcSEcCtD
Cyproterone acetate—Pancreatitis—Epirubicin—liver cancer	0.00131	0.00195	CcSEcCtD
Cyproterone acetate—Vomiting—Sorafenib—liver cancer	0.0013	0.00194	CcSEcCtD
Cyproterone acetate—Rash—Sorafenib—liver cancer	0.00129	0.00193	CcSEcCtD
Cyproterone acetate—Dermatitis—Sorafenib—liver cancer	0.00129	0.00193	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—liver cancer	0.00129	0.00192	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00128	0.00192	CcSEcCtD
Cyproterone acetate—Headache—Sorafenib—liver cancer	0.00128	0.00192	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.00128	0.00404	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00127	0.00399	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00126	0.00398	CbGpPWpGaD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00126	0.00188	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—liver cancer	0.00126	0.00188	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00125	0.00393	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—JUN—liver cancer	0.00124	0.00392	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—liver cancer	0.00124	0.0039	CbGpPWpGaD
Cyproterone acetate—Asthma—Doxorubicin—liver cancer	0.00123	0.00184	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.00123	0.00388	CbGpPWpGaD
Cyproterone acetate—Pollakiuria—Epirubicin—liver cancer	0.00123	0.00184	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00122	0.00386	CbGpPWpGaD
Cyproterone acetate—Nausea—Sorafenib—liver cancer	0.00122	0.00182	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—liver cancer	0.00122	0.00181	CcSEcCtD
Cyproterone acetate—Weight increased—Epirubicin—liver cancer	0.00121	0.00181	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—liver cancer	0.00121	0.0018	CcSEcCtD
Cyproterone acetate—Weight decreased—Epirubicin—liver cancer	0.0012	0.0018	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.0012	0.00378	CbGpPWpGaD
Cyproterone acetate—Hyperglycaemia—Epirubicin—liver cancer	0.0012	0.00179	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.0012	0.00377	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00118	0.00372	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00118	0.00372	CbGpPWpGaD
Cyproterone acetate—Renal failure—Epirubicin—liver cancer	0.00117	0.00174	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.00115	0.00361	CbGpPWpGaD
Cyproterone acetate—Sweating—Epirubicin—liver cancer	0.00114	0.0017	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—liver cancer	0.00114	0.0017	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—liver cancer	0.00114	0.00358	CbGpPWpGaD
Cyproterone acetate—Haematuria—Epirubicin—liver cancer	0.00113	0.00169	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—liver cancer	0.00113	0.00355	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—liver cancer	0.00112	0.00168	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—liver cancer	0.00112	0.00354	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—liver cancer	0.00112	0.00168	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—liver cancer	0.00112	0.00167	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.00112	0.00351	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Doxorubicin—liver cancer	0.00111	0.00166	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—liver cancer	0.00111	0.00166	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—liver cancer	0.00108	0.00161	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—JUN—liver cancer	0.00107	0.00338	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Epirubicin—liver cancer	0.00107	0.0016	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—liver cancer	0.00107	0.0016	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—liver cancer	0.00107	0.00159	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—liver cancer	0.00107	0.00159	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00106	0.00334	CbGpPWpGaD
Cyproterone acetate—Sweating—Doxorubicin—liver cancer	0.00105	0.00157	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—liver cancer	0.00105	0.00156	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—liver cancer	0.00105	0.00156	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—liver cancer	0.00104	0.00327	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—liver cancer	0.00104	0.00155	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—liver cancer	0.00104	0.00327	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Epirubicin—liver cancer	0.00103	0.00153	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—liver cancer	0.00102	0.00322	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00101	0.0032	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Epirubicin—liver cancer	0.00101	0.0015	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.00101	0.00317	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.001	0.00316	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—liver cancer	0.000998	0.00314	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Epirubicin—liver cancer	0.000996	0.00149	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.000993	0.00313	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Doxorubicin—liver cancer	0.000991	0.00148	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—liver cancer	0.000986	0.00147	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—liver cancer	0.000986	0.00147	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—liver cancer	0.000973	0.00307	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.000971	0.00306	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00097	0.00305	CbGpPWpGaD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—liver cancer	0.000969	0.00145	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—liver cancer	0.000967	0.00144	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—liver cancer	0.000963	0.00144	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—liver cancer	0.000961	0.00143	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—liver cancer	0.00096	0.00302	CbGpPWpGaD
Cyproterone acetate—Chills—Epirubicin—liver cancer	0.000956	0.00143	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—liver cancer	0.000951	0.00299	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Doxorubicin—liver cancer	0.00095	0.00142	CcSEcCtD
Cyproterone acetate—Alopecia—Epirubicin—liver cancer	0.000942	0.00141	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—liver cancer	0.000934	0.00139	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.000934	0.00294	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Doxorubicin—liver cancer	0.000933	0.00139	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—liver cancer	0.000928	0.00138	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—liver cancer	0.000922	0.00138	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000921	0.0029	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—liver cancer	0.000918	0.00289	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—liver cancer	0.000915	0.00288	CbGpPWpGaD
Cyproterone acetate—Tension—Epirubicin—liver cancer	0.000911	0.00136	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NR1H4—liver cancer	0.00091	0.00287	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.000904	0.00285	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.000895	0.00282	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—liver cancer	0.000895	0.00134	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NR1I3—liver cancer	0.000895	0.00282	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Doxorubicin—liver cancer	0.000891	0.00133	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—liver cancer	0.000889	0.00133	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—liver cancer	0.000885	0.00132	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.000882	0.00278	CbGpPWpGaD
Cyproterone acetate—Alopecia—Doxorubicin—liver cancer	0.000872	0.0013	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—liver cancer	0.000864	0.00129	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—liver cancer	0.000861	0.00128	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—liver cancer	0.000859	0.00128	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—liver cancer	0.000858	0.00128	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GGT1—liver cancer	0.000857	0.0027	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—liver cancer	0.000853	0.00127	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—liver cancer	0.000843	0.00126	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—liver cancer	0.000837	0.00125	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.000835	0.00263	CbGpPWpGaD
Cyproterone acetate—Syncope—Epirubicin—liver cancer	0.000832	0.00124	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—liver cancer	0.000831	0.00124	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Epirubicin—liver cancer	0.000816	0.00122	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.000813	0.00256	CbGpPWpGaD
Cyproterone acetate—Cough—Epirubicin—liver cancer	0.00081	0.00121	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000804	0.00253	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—liver cancer	0.000797	0.00119	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—liver cancer	0.000794	0.00118	CcSEcCtD
Cyproterone acetate—Agitation—Doxorubicin—liver cancer	0.000789	0.00118	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000785	0.00117	CcSEcCtD
Cyproterone acetate—Discomfort—Epirubicin—liver cancer	0.000781	0.00116	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—liver cancer	0.000774	0.00116	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—liver cancer	0.000773	0.00243	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.000772	0.00243	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—liver cancer	0.000771	0.00243	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.00077	0.00243	CbGpPWpGaD
Cyproterone acetate—Syncope—Doxorubicin—liver cancer	0.00077	0.00115	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00077	0.00242	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Doxorubicin—liver cancer	0.000769	0.00115	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—liver cancer	0.000765	0.00241	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000764	0.00241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.00076	0.00239	CbGpPWpGaD
Cyproterone acetate—Oedema—Epirubicin—liver cancer	0.000757	0.00113	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—liver cancer	0.000755	0.00113	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—liver cancer	0.00075	0.00236	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—liver cancer	0.000749	0.00112	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—liver cancer	0.000745	0.00111	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Epirubicin—liver cancer	0.000743	0.00111	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—liver cancer	0.000741	0.00111	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00074	0.00233	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Epirubicin—liver cancer	0.000739	0.0011	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.000736	0.00232	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Epirubicin—liver cancer	0.000736	0.0011	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Epirubicin—liver cancer	0.000732	0.00109	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000726	0.00108	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—liver cancer	0.000722	0.00108	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—liver cancer	0.000722	0.00108	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.000717	0.00226	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—liver cancer	0.00071	0.00224	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—JUN—liver cancer	0.000708	0.00223	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.000708	0.00223	CbGpPWpGaD
Cyproterone acetate—Hypotension—Epirubicin—liver cancer	0.000708	0.00106	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—liver cancer	0.000703	0.00221	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—liver cancer	0.000701	0.00105	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.000698	0.0022	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.00069	0.00217	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00069	0.00217	CbGpPWpGaD
Cyproterone acetate—Shock—Doxorubicin—liver cancer	0.000689	0.00103	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—liver cancer	0.000687	0.00103	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—liver cancer	0.000687	0.00216	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—liver cancer	0.000686	0.00102	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.000684	0.00215	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Doxorubicin—liver cancer	0.000684	0.00102	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000683	0.00215	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Doxorubicin—liver cancer	0.000681	0.00102	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.000679	0.00214	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—liver cancer	0.000677	0.00101	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—PPARA—liver cancer	0.000677	0.00213	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Epirubicin—liver cancer	0.000675	0.00101	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.000671	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.000669	0.00211	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—liver cancer	0.000668	0.000997	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—liver cancer	0.000667	0.000995	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000662	0.00208	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.000661	0.00208	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Epirubicin—liver cancer	0.000658	0.000982	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000658	0.00207	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—liver cancer	0.000655	0.000977	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000654	0.000975	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—liver cancer	0.000653	0.000974	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.000652	0.00205	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.000651	0.00205	CbGpPWpGaD
Cyproterone acetate—Constipation—Epirubicin—liver cancer	0.000648	0.000966	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.000646	0.00204	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000637	0.00201	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.000633	0.002	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—liver cancer	0.000625	0.000932	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—liver cancer	0.000624	0.000931	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000624	0.00196	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—HNF4A—liver cancer	0.00062	0.00195	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—liver cancer	0.00062	0.00195	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—liver cancer	0.000619	0.000924	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.000617	0.00194	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Doxorubicin—liver cancer	0.000617	0.00092	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000614	0.00193	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—liver cancer	0.000613	0.00193	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—liver cancer	0.000609	0.000909	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000606	0.00191	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000605	0.000903	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—liver cancer	0.000604	0.000901	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—liver cancer	0.000602	0.000898	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—liver cancer	0.000599	0.000894	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—liver cancer	0.000599	0.000893	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—liver cancer	0.000599	0.000893	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000594	0.00187	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.00059	0.00186	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000579	0.00182	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—liver cancer	0.000577	0.000862	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.000574	0.00181	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000573	0.000855	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000562	0.00177	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000562	0.00177	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—liver cancer	0.000559	0.00176	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—liver cancer	0.000558	0.000832	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—liver cancer	0.000557	0.000831	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.000556	0.00175	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Doxorubicin—liver cancer	0.000554	0.000826	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—liver cancer	0.000554	0.000826	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EXOSC2—liver cancer	0.00055	0.00173	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000548	0.00173	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—liver cancer	0.000543	0.000811	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000543	0.00171	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000537	0.00169	CbGpPWpGaD
Cyproterone acetate—Pruritus—Epirubicin—liver cancer	0.000536	0.000799	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.000534	0.00168	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—liver cancer	0.000534	0.00168	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000526	0.00166	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.000523	0.00165	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.000522	0.00164	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000519	0.00164	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—liver cancer	0.000518	0.000773	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—liver cancer	0.000516	0.00077	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000504	0.00159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000503	0.00159	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—liver cancer	0.000503	0.00075	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—UGDH—liver cancer	0.000502	0.00158	CbGpPWpGaD
Cyproterone acetate—Dizziness—Epirubicin—liver cancer	0.000501	0.000747	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—liver cancer	0.000496	0.00074	CcSEcCtD
Cyproterone acetate—Vomiting—Epirubicin—liver cancer	0.000482	0.000718	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—liver cancer	0.000479	0.000715	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000478	0.0015	CbGpPWpGaD
Cyproterone acetate—Rash—Epirubicin—liver cancer	0.000477	0.000712	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—liver cancer	0.000477	0.000712	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—liver cancer	0.000474	0.000708	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—EPT1—liver cancer	0.000472	0.00149	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.00047	0.00148	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000466	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000465	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000465	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000464	0.00146	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—liver cancer	0.000463	0.000691	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.00046	0.00145	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—liver cancer	0.000452	0.00142	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—liver cancer	0.00045	0.000671	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000449	0.00141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TAT—liver cancer	0.000447	0.00141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000447	0.00141	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—liver cancer	0.000446	0.000665	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—liver cancer	0.000442	0.000659	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—liver cancer	0.000441	0.000659	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000441	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00044	0.00139	CbGpPWpGaD
Cyproterone acetate—Headache—Doxorubicin—liver cancer	0.000439	0.000655	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NR1H4—liver cancer	0.000438	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR1I3—liver cancer	0.000431	0.00136	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.00043	0.00135	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000426	0.00134	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000418	0.00132	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—liver cancer	0.000416	0.000621	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000411	0.00129	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000405	0.00128	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000404	0.00127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.0004	0.00126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000399	0.00126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000396	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000396	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000395	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.000395	0.00124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000394	0.00124	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000393	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000385	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000385	0.00121	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000384	0.00121	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000382	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000379	0.00119	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000373	0.00117	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000373	0.00117	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000364	0.00115	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000353	0.00111	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000349	0.0011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000347	0.00109	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000345	0.00109	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—liver cancer	0.000343	0.00108	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000343	0.00108	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00034	0.00107	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—liver cancer	0.000338	0.00107	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000336	0.00106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR1H4—liver cancer	0.000332	0.00105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000329	0.00104	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR1I3—liver cancer	0.000327	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARA—liver cancer	0.000326	0.00103	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000323	0.00102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000321	0.00101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.00032	0.00101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000318	0.001	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000309	0.000973	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000308	0.000971	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000306	0.000965	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CPT1B—liver cancer	0.000304	0.000957	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLUL—liver cancer	0.000304	0.000957	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.0003	0.000944	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNF4A—liver cancer	0.000299	0.00094	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—liver cancer	0.000297	0.000936	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000297	0.000934	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—liver cancer	0.000295	0.00093	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NR1H4—liver cancer	0.000293	0.000923	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA3—liver cancer	0.000288	0.000908	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000288	0.000907	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000286	0.000899	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—liver cancer	0.000273	0.00086	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—liver cancer	0.000269	0.000848	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA4—liver cancer	0.000264	0.00083	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000264	0.00083	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000262	0.000826	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMA4—liver cancer	0.000261	0.000822	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMD10—liver cancer	0.000261	0.000822	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000259	0.000815	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000258	0.000811	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA2—liver cancer	0.000257	0.000809	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000257	0.000809	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000254	0.000799	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA1—liver cancer	0.000248	0.000781	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000247	0.000778	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAT2—liver cancer	0.000245	0.000772	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—liver cancer	0.000243	0.000764	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—liver cancer	0.00024	0.000755	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000236	0.000742	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDOB—liver cancer	0.000235	0.00074	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HNF4A—liver cancer	0.000227	0.000713	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CRABP1—liver cancer	0.000224	0.000706	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.000224	0.000705	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000223	0.000701	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000214	0.000675	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000207	0.000653	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000204	0.000643	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000202	0.000636	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMD10—liver cancer	0.000198	0.000624	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMA4—liver cancer	0.000198	0.000624	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HPGDS—liver cancer	0.000196	0.000617	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000195	0.000613	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000184	0.00058	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000177	0.000559	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H2AFX—liver cancer	0.000176	0.000555	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000175	0.000552	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMD10—liver cancer	0.000175	0.00055	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMA4—liver cancer	0.000175	0.00055	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT2—liver cancer	0.00017	0.000535	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—liver cancer	0.00016	0.000503	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARA—liver cancer	0.000157	0.000494	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000155	0.000487	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—liver cancer	0.000154	0.000483	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYCS—liver cancer	0.000149	0.000471	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT1—liver cancer	0.000147	0.000462	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT1—liver cancer	0.000147	0.000462	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK14—liver cancer	0.000145	0.000456	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—liver cancer	0.000142	0.000448	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—H2AFX—liver cancer	0.000134	0.000421	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—liver cancer	0.000132	0.000415	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—liver cancer	0.00013	0.000409	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—liver cancer	0.00013	0.000408	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—liver cancer	0.000121	0.000381	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARA—liver cancer	0.000119	0.000375	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—liver cancer	0.000117	0.000368	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.000116	0.000367	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—liver cancer	0.000115	0.000361	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK14—liver cancer	0.00011	0.000346	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—liver cancer	0.000108	0.00034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—liver cancer	0.000107	0.000337	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARA—liver cancer	0.000105	0.000331	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—liver cancer	9.83e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.43e-05	0.000297	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—liver cancer	8.99e-05	0.000283	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—liver cancer	8.86e-05	0.000279	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—liver cancer	8.67e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—liver cancer	7.9e-05	0.000249	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—liver cancer	7.8e-05	0.000246	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—liver cancer	7.39e-05	0.000233	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—liver cancer	6.89e-05	0.000217	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—liver cancer	5.61e-05	0.000177	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—liver cancer	5.13e-05	0.000161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—liver cancer	4.2e-05	0.000132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—liver cancer	3.89e-05	0.000122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—liver cancer	3.43e-05	0.000108	CbGpPWpGaD
